Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydrocannabinol (THC) detection and quantification; Cannabix breath collection unit and breath cartridge for human breath sample collection, storage, and transportation. The company also provides BreathLogix alcohol breathalyzer, an autonomous alcohol screening system that enables screening of employees, contractors, and visitors in mining, construction, and oil and gas industries; and BreathLogix Connect (BLC), a cloud platform that is designed for streamlining data. It has a strategic partnership and development agreement with Omega Laboratories Inc. for the development and commercialization of the MBT technology. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.